Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2021-09-10 00:00:00 ET · period of report 2021-04-16 · accession 0001209191-21-055496 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-10 | 2021-04-16+ | CPIX | KAZIMI A J | COB, CEO, Dir, 10% | P - Purchase | $2.88 | +450 | 5.77M | +0.0% | +$1,294 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-05-24 | P | A | 15 | $3.05 | 5,768,124 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 2 | Common | Common Stock | 2021-05-25 | P | A | 15 | $2.91 | 5,768,139 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 3 | Common | Common Stock | 2021-05-26 | P | A | 15 | $2.85 | 5,768,154 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 4 | Common | Common Stock | 2021-04-16 | P | A | 15 | $3.03 | 5,767,734 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 5 | Common | Common Stock | 2021-04-19 | P | A | 15 | $3.04 | 5,767,749 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 6 | Common | Common Stock | 2021-04-20 | P | A | 15 | $3.02 | 5,767,764 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 7 | Common | Common Stock | 2021-04-21 | P | A | 15 | $2.97 | 5,767,779 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 8 | Common | Common Stock | 2021-04-22 | P | A | 15 | $2.96 | 5,767,794 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 9 | Common | Common Stock | 2021-04-23 | P | A | 15 | $2.99 | 5,767,809 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 10 | Common | Common Stock | 2021-04-26 | P | A | 15 | $2.97 | 5,767,824 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 11 | Common | Common Stock | 2021-05-19 | P | A | 15 | $2.83 | 5,768,079 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 12 | Common | Common Stock | 2021-04-28 | P | A | 15 | $2.94 | 5,767,854 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 13 | Common | Common Stock | 2021-04-29 | P | A | 15 | $2.89 | 5,767,869 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 14 | Common | Common Stock | 2021-04-30 | P | A | 15 | $2.78 | 5,767,884 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 15 | Common | Common Stock | 2021-05-03 | P | A | 15 | $2.66 | 5,767,899 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 16 | Common | Common Stock | 2021-05-04 | P | A | 15 | $2.66 | 5,767,914 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 17 | Common | Common Stock | 2021-05-05 | P | A | 15 | $2.73 | 5,767,929 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 18 | Common | Common Stock | 2021-05-06 | P | A | 15 | $2.74 | 5,767,944 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 19 | Common | Common Stock | 2021-05-07 | P | A | 15 | $2.73 | 5,767,959 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 20 | Common | Common Stock | 2021-05-10 | P | A | 15 | $2.71 | 5,767,974 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 21 | Common | Common Stock | 2021-05-11 | P | A | 15 | $2.68 | 5,767,989 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 22 | Common | Common Stock | 2021-05-12 | P | A | 15 | $2.86 | 5,768,004 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 23 | Common | Common Stock | 2021-05-13 | P | A | 15 | $2.88 | 5,768,019 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 24 | Common | Common Stock | 2021-05-14 | P | A | 15 | $2.81 | 5,768,034 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 25 | Common | Common Stock | 2021-05-17 | P | A | 15 | $2.84 | 5,768,049 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 26 | Common | Common Stock | 2021-05-18 | P | A | 15 | $2.89 | 5,768,064 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 27 | Common | Common Stock | 2021-05-21 | P | A | 15 | $3.06 | 5,768,109 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 28 | Common | Common Stock | 2021-05-20 | P | A | 15 | $2.94 | 5,768,094 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 29 | Common | Common Stock | 2021-05-27 | P | A | 15 | $2.94 | 5,768,169 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 30 | Common | Common Stock | 2021-04-27 | P | A | 15 | $2.94 | 5,767,839 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |